feed,title,long_url,short_url
Benzinga,NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical Officer,https://www.benzinga.com/pressreleases/20/07/g16600095/nextcure-provides-an-interim-update-of-the-phase-2-portion-of-the-nc318-monotherapy-phase-12-trial,https://j.mp/2Oj84LT
